Fructosamine oxidase: antagonists and inhibitors
US6348465B1 · kind B1 · utility
31Cited by
10References
35Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 27, 2000 |
| Grant date | Feb 19, 2002 |
| Priority date | — |
| Expiry date | Sep 27, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods of treating an individual with diabetes mellitus by administering to said individual an effective amount of copper chelators, hydrazine compounds, and/or substrate analogues. The invention also relates to methods of treating an individual with diabetes mellitus by lessening frictosamine odixase activity in said individual. Provided within is disclosure pertaining to treatment, pharmaceutical compositions, dosage ranges, and uses of frictosaminc oxidase enzyme inhibitors to lessen fructosamine oxidase activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.